Successful treatment of nasal T-cell lymphoma with a combination of local irradiation and high-dose chemotherapy

International Journal of Hematology

Volumn 75, Issue 2, 2002, Pages 195-200

  Sanda, Takaomi ^a   Iida, Shinsuke ^a   Ito, Masato ^a   Tsuboi, Kazuya ^a   Miura, Kazuhisa ^a   Harada, Shinsuke ^a   Komatsu, Hirokazu ^a   Wakita, Atsushi ^a   Inagaki, Hiroshi ^a   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation; Combined modality therapy; Local irradiation; Nasal T cell lymphoma

Indexed keywords

CD3 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; VINCRISTINE; ANTINEOPLASTIC AGENT; VAP CYCLO PROTOCOL; VAP-CYCLO PROTOCOL;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; NATURAL KILLER T CELL LYMPHOMA; T CELL LYMPHOMA; TREATMENT OUTCOME; VIRUS INFECTION; ADJUVANT THERAPY; AUTOTRANSPLANTATION; MIDDLE AGED; NOSE TUMOR; REMISSION; STEM CELL TRANSPLANTATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, T-CELL; MIDDLE AGED; NOSE NEOPLASMS; PREDNISOLONE; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 17144460920     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982028     Document Type: Article

References (28)

1. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70-77.
2. Chan JK, Sin VC, Wong KF, et al. Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of uncommon aggressive neoplasm. Blood. 1997;89:4501-4513.
3. Jaffe ES, Chan JK, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.
4. Shih LY, Linag DC. Non-Hodgkin's lymphoma in Asia. Hematol Oncol Clin North Am. 1991;5:983-1001.
5. Ho FCS, Todd D, Loke SL, et al. Clinico-pathological features of malignant lymphoma in 294 Hong Kong Chinese patients - a retrospective study covering an eight-year period. Int J Cancer. 1984;34:143-148.
6. Liang R, Todd D, Chan TK, et al. Nasal lymphoma, a retrospective analysis of 60 cases. Cancer. 1990;66:2205-2209.
7. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphoma in patients with lethal midline granuloma. Lancet. 1990;335:128-130.
8. Mishima K, Horiuchi K, Kojya S, et al. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer. 1994;73:3041-3046.
9. O'Leary G, Kennedy SM. Association of Epstein-Barr virus with sinonasal angiocentric T cell lymphoma. J Clin Pathol. 1995;48:946-949.
10. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphoma. Blood. 1994;83:2255-2260.
11. Chiang AKS, Chan ACL, Srivastava G, et al. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer. 1997;73:332-338.
12. Chiang AKS, Arivastava G, Lau PWF, et al. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin. Hum Pathol. 1996;27:701-707.
13. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood. 1996;87:1474-1483.
14. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996;87:1207-1210.
15. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998;339:21-26.
16. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
17. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
18. Van Gorp J, De Bruin PC, Sie-Go DM, et al. Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathology. 1995;27:139-148.
19. Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer. 1996;77:2137-2149.
20. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81:2688-2695.
21. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91:1723-1731.
22. Kessinger A, Armitage JO, Smith DO, et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood. 1989;74:1260-1265.
23. Armitage JO. Autologous bone marrow transplantation for patient with aggressive non-Hodgkin's lymphoma. Bone Marrow Transplant. 1992;10:62-63.
24. Nademanee A, Molina A, O'Donnell MR, et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group. Blood. 1997;90:3844-3852.
25. Liang R, Chen F, Lee CK, et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant. 1997;19:91-93.
26. Sasaki M, Matsue K, Takeuchi M, et al. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation. Int J Hematol. 2000;71:75-78.
27. Liang R, Todd D, Chiu E, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 1995;13:666-670.
28. Shying MM, Chan JO, Lau WHY, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70-77.